ADOLOR CORP (NASDAQ: ADLR)





$1.46 0.01 (0.69%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
2.53
52-Week Low Price
1.33
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.07 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-1.10
Shares
46.33 M
Dividend Rate ($) / (%)
0.00/0.00
100%
0%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -40% - ADLR has underperformed the S&P 500 by 66%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
BIODELIV SCIENCES INTL (BDSI) $3.50 -  $0.02(0.57%)0.07 B
NEPTUNE TECH & BIORESRCS (NEPT) $2.03 -  $0.07(3.57%)0.07 B
INTERNATIONAL STEM CELL (ISCO) $1.40 -  $0.41(41.41%)0.07 B
SOMAXON PHARMACEUTICALS (SOMX) $2.76 -  $0.08(2.99%)0.07 B
WEIKANG BIO-TECH GP CO (WKBT) $2.50 -  $0.00(0.00%)0.07 B
LOTUS PHARMACEUTICALS (LTUS) $1.40 -  $0.03(2.10%)0.07 B
ANTIGENICS INC (AGEN) $0.75 -  $0.02(2.57%)0.07 B
ENTREMED INC (ENMD) $0.83 -  $0.03(4.40%)0.07 B
MEDIZONE INTERNAT INC (MZEI) $0.27 -  $0.00(0.00%)0.07 B
POLYMEDIX INC (PYMX) $1.07 -  $0.01(0.94%)0.07 B
STOCK ANALYSIS
There are currently no Stock Analysis.
ADLR RELATED HEADLINES
arrow
Healthcare Stocks Galore
<ul> <li>Clarient's breast cancer technology for treatment</li> <li>Biomeds brain cancer drug in Phase III</li> <li>Medarexs 6 clinical candidates for '09 and '10</li> </ul>

Wall Street Media 12/11/2008
arrow
Study Published in Archives of Surgery Demonstrated Benefit of ENTEREG® (alvimopan) in Postoperative Ileus
Study Published in Archives of Surgery Demonstrated Benefit of ENTEREG® (alvimopan) in Postoperative Ileus

At BusinessWire 11/18/2008
arrow
Adolor Corporation Reports Third Quarter 2008 Financial Results
Adolor Corporation Reports Third Quarter 2008 Financial Results

At BusinessWire 10/28/2008
arrow
FACTBOX-US regulators missing drug review deadlines
DRUGS/DELAYS (FACTBOX):FACTBOX-US regulators missing drug review deadlines

Forbes.com 10/17/2008
arrow
Adolor Appoints John M. Limongelli as Senior Vice President, General Counsel and Secretary
Adolor Appoints John M. Limongelli as Senior Vice President, General Counsel and Secretary

At BusinessWire 9/10/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1